Media Release | May 15, 2017
In one of the most comprehensive studies to date, UBC researchers have identified potential adverse reactions of a commonly used multiple sclerosis drug.
Media Release | April 21, 2017
People with multiple sclerosis can show signs of something wrong five years before the onset of disease, much earlier than previously thought, according to a new analysis of health records from people with the condition.
Media Release | June 1, 2016
Scientists at the University of British Columbia and Vancouver Coastal Health have proven that multiple sclerosis (MS) can be caused by a single genetic mutation.
Media Release | October 8, 2013
A UBC-Vancouver Coastal Health study calls into question a controversial theory that MS is associated with a disorder proponents call chronic cerebrospinal venous insufficiency
Media Release | June 12, 2013
UBC researchers have developed a MRI technique to detect multiple sclerosis.
Media Release | October 17, 2012
Multiple sclerosis (MS) patients sometimes experience “natural” improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health Research Institute.
Widely prescribed MS treatment may not slow progression of disease: Vancouver Coastal Health and UBC Research
Media Release | July 17, 2012
Researchers with the UBC Hospital MS Clinic and Brain Research Centre at Vancouver Coastal Health and the University of British Columbia have published important data in the Journal of the American Medical Association (JAMA) about the impact of a common drug therapy on the progression of multiple sclerosis for people with the relapse-remitting form of the disease.
Media Release | June 21, 2012
Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health. The […]
Media Release | September 15, 2011
A group led by a University of British Columbia and Vancouver Coastal Health scientist has discovered a type of spinal cord cell that could function as a stem cell, with the ability to regenerate portions of the central nervous system in people with spinal cord injuries, multiple sclerosis or amyotrophic lateral sclerosis (Lou Gehrig’s disease).
Media Release | June 11, 2010
A team of researchers from the University of British Columbia, Vancouver Coastal Health Research Institute and the University of Saskatchewan has been selected by the Multiple Sclerosis Society of Canada and the National MS Society to assess whether a syndrome known as chronic cerebrospinal venous insufficiency has a role in MS.